Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Phase III trial comparing 3–6 months of adjuvant FOLFOX4/XELOX in stage II–III colon cancer: safety and compliance in the TOSCA trial
PaperCitations, authors & open-access status
Phase III trial comparing 3–6 months of adjuvant FOLFOX4/XELOX in stage II–III colon cancer: safety and compliance in the TOSCA trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 56 citations, 2016 year and bronze oa status.
56
Citations
2016
Year
bronze
OA Status